Dipraglurant pharmacokinetics and tolerability in older volunteers.
Phase of Trial: Phase I
Latest Information Update: 28 Jan 2009
At a glance
- Drugs Dipraglurant (Primary)
- Indications Drug-induced dyskinesia; Parkinson's disease
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Addex Therapeutics
- 28 Jan 2009 Status changed from recruiting to completed, as reported in an Addex Pharmaceuticals media release.
- 28 Oct 2008 New trial record.
- 15 Oct 2008 According to Addex Pharmaceuticals, topline results are expected before the end of 2008.